Monthly Archives: May 2022

Abstract:  “Stroke is the fourth leading cause of death in the United States and the leading cause of long-term disability. Ischemic stroke, due to an interruption in blood supply, is particularly prevalent; 87% of all strokes are ischemic. Unfortunately, current … Continue reading

Posted in Uncategorized | Comments Off on A rat’s whiskers point the way toward a novel stimulus-dependent, protective stroke therapy

“Survivors of extreme adverse events, including natural disasters, often exhibit chronic inflammation and early onset of age-related diseases. Adversity may therefore accelerate aging via the immune system, which is sensitive to lived experiences. We tested if experiencing a hurricane was … Continue reading

Posted in Uncategorized | Comments Off on Natural disaster and immunological aging

Summary highlights: The increase in striatal volume in psychopathic individuals is not an artefact of psychiatric comorbidity. Increased striatal volumes were associated with greater psychopathic traits in males and in a small female sample. The need for stimulation and impulsivity … Continue reading

Posted in Uncategorized | Comments Off on Larger striatal volume is associated with increased adult psychopathy

Abstract In this issue of Cell, Wei et al. show that the increased cardiovascular risks associated with cannabis use are mediated by proinflammatory cannabinoid 1 (CB1) receptor signaling, which can be ameliorated with the natural antioxidant agent genistein. Sakmar TP. … Continue reading

Posted in Uncategorized | Comments Off on Getting to the heart of cannabis health risks

Abstract: “The prevalence of autoimmune diseases (ADs) worldwide has rapidly increased over the past few decades. Thus, in addition to the classical risk factors for ADs, such as genetic polymorphisms, infections and smoking, environmental triggers have been considered. Recent sequencing-based … Continue reading

Posted in Uncategorized | Comments Off on The impact of the gut microbiome on extra-intestinal autoimmune diseases

Abstract: “The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accelerates the discovery of prophylactic and therapeutic drugs for persons infected with the virus. Drug repurposing for the COVID-19 pandemic has … Continue reading

Posted in Uncategorized | Comments Off on Mechanisms of action of fluvoxamine for COVID-19: a historical review

Abstract:  “Human brain structure changes throughout the lifespan. Altered brain growth or rates of decline are implicated in a vast range of psychiatric, developmental and neurodegenerative diseases. In this study, we identified common genetic variants that affect rates of brain … Continue reading

Posted in Uncategorized | Comments Off on Genetic variants associated with longitudinal changes in brain structure across the lifespan